NOTICE TO DISREGARD -- ICARO Media Group

Posted 12/8/2025 12:27:11 AM- GlobeNewsWire

SED Initta and Intel Deepen Strategic Partnership to Accelerate AI-Driven Retail Transformation

Posted 12/8/2025 12:20:40 AM- GlobeNewsWire

HVAC Expert Ben Fleck of Gretna Advises Homeowners to Change Air Filters Regularly in HelloNation

Posted 12/8/2025 12:09:26 AM- GlobeNewsWire

Pest Control Expert Steven Moore of Port Washington Shares The Top 4 Household Pests for HelloNation

Posted 12/8/2025 12:06:30 AM- GlobeNewsWire

Collision Repair Expert Andy Spence of Jackson, TN, Explains Why Certified Collision Repair Matters for HelloNation

Posted 12/8/2025 12:05:18 AM- GlobeNewsWire

Retail Expert Melissa Skelton Shares Insights on Custom vs. Commercial Easter Gifts in New HelloNation Feature

Posted 12/8/2025 12:03:09 AM- GlobeNewsWire

Laser Hair Removal Expert Dr. Terese Thomas, MD Explains Sublative Radiofrequency vs Facial in HelloNation

Posted 12/8/2025 12:01:27 AM- GlobeNewsWire

Marine Transport Expert Jon Arrigoni of Arrigoni Marine Movers Warns Boat Owners About Insurance Gaps in HelloNation

Posted 12/8/2025 12:00:08 AM- GlobeNewsWire

HeroFlow Announces Expansion of Access to “The AI Employee,” the 24/7 Virtual Receptionist That Never Calls In Sick

Posted 12/7/2025 9:14:46 PM- GlobeNewsWire

Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: The FX Super One First Pre-Production Vehicles Roll-off Ceremony is Scheduled for December 21 at the Company’s Hanford, CA Factory

Posted 12/7/2025 9:09:27 PM- GlobeNewsWire

The Ohio State University’s Caleb Downs Named Winner of Lott IMPACT Trophy Presented by Allied Universal

Posted 12/7/2025 9:04:55 PM- GlobeNewsWire

OPay Appoints Former Citigroup Managing Director James Perry as CFO

Posted 12/7/2025 8:59:00 PM- GlobeNewsWire

ASH 2025 | Ascentage Pharma Presents Encouraging Data from Phase Ib/II Study of Bcl-2 Inhibitor Lisaftoclax in Venetoclax–Exposed Patients with Myeloid Malignances

Posted 12/7/2025 8:10:00 PM- GlobeNewsWire

Skyline Digital Marketing Introduces Proprietary Skyline Methodology to Strengthen Data-Driven Business Growth

Posted 12/7/2025 7:54:22 PM- GlobeNewsWire

HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List and Inclusion in the First Commercial Insurance Drug List in China

Posted 12/7/2025 7:00:00 PM- GlobeNewsWire

Structure Therapeutics to Report Data from ACCESS Clinical Program of Oral Small Molecule GLP-1 Receptor Agonist, Aleniglipron, on December 8, 2025

Posted 12/7/2025 6:20:23 PM- GlobeNewsWire

Immix Biopharma Announces Pricing of Upsized $100 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Posted 12/7/2025 6:20:00 PM- GlobeNewsWire

At ASH 2025 Oral Presentation, Immix Biopharma Reports Positive Phase 2 NXC-201 Results, Advancing Toward BLA Submission as a Potentially First- and Best-in-Class Therapy for relapsed/refractory AL Amyloidosis

Posted 12/7/2025 6:15:00 PM- GlobeNewsWire

SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025

Posted 12/7/2025 6:00:00 PM- GlobeNewsWire

Lime & Lemon Apex Redefines the Dining Scene with an Experience the Triangle Was Waiting For

Posted 12/7/2025 5:35:14 PM- GlobeNewsWire

ImCheck Reports Durable Responses and Early Overall Survival Signal with ICT01 in First-line AML at ASH 2025

Posted 12/7/2025 5:33:00 PM- GlobeNewsWire

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Posted 12/7/2025 5:30:00 PM- GlobeNewsWire

Lynozyfic™ (linvoseltamab) Monotherapy in Newly Diagnosed Multiple Myeloma (NDMM) Shows Impressive Responses, Supporting Rationale as a Potential Foundation in Frontline Treatment

Posted 12/7/2025 4:30:00 PM- GlobeNewsWire

Lyell Immunopharma Presents New Clinical Data from Ongoing Trial of Ronde-Cel Showing High Rates of Durable Complete Responses in Patients with Large B-cell Lymphoma at the 67th ASH Annual Meeting and Exposition

Posted 12/7/2025 4:30:00 PM- GlobeNewsWire

Wave Life Sciences to Announce Interim Data from the Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity on Monday, December 8, 2025

Posted 12/7/2025 4:00:00 PM- GlobeNewsWire

Rally House Breaks Company Online Sales Record After Electric Sports Weekend

Posted 12/7/2025 3:56:18 PM- GlobeNewsWire

Dyne Therapeutics to Host Investor Conference Call and Webcast to Review Topline Results from Registrational Expansion Cohort (REC) of DELIVER Clinical Trial of Z-Rostudirsen (DYNE-251) in Duchenne Muscular Dystrophy; Tomorrow, December 8 at 8:00 a.m. ET

Posted 12/7/2025 11:00:00 AM- GlobeNewsWire

Nayax Considering an Offering of Notes and Warrants in Israel

Posted 12/7/2025 9:30:00 AM- GlobeNewsWire

Real Estate Expert Kerry Ramage of Melbourne, FL, Breaks Down Home Sale Strategy for HelloNation

Posted 12/7/2025 8:07:18 AM- GlobeNewsWire

Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease

Posted 12/7/2025 8:05:00 AM- GlobeNewsWire

Secura Bio Presents Extended Follow Up Analyses from Phase 2 PRIMO Trial in Patients with Relapsed/Refractory peripheral T-cell lymphoma at the 2025 American Society of Hematology Meeting

Posted 12/7/2025 8:01:00 AM- GlobeNewsWire

Mutuum Finance (MUTM) Approaches 100% Presale Sellout Amid Ongoing Halborn Security Review

Posted 12/7/2025 8:00:00 AM- GlobeNewsWire

ALX Oncology Announces Positive Results from Ongoing Investigator-Sponsored Phase 2 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with Indolent B-cell Non-Hodgkin Lymphoma, at ASH Annual Meeting

Posted 12/7/2025 8:00:00 AM- GlobeNewsWire

Manufacturing Expert James Gizzi of Rochester Discusses How to Choose a CNC Machine Shop in HelloNation

Posted 12/7/2025 7:54:32 AM- GlobeNewsWire

How Roofing Expert Tom Meadows of Ann Arbor Explains Roof Repair vs. Roof Replacement for HelloNation

Posted 12/7/2025 7:49:58 AM- GlobeNewsWire

Molecular Partners Presents Updated Data from Ongoing Phase 1/2a Trial of MP0533 in AML at ASH Annual Meeting

Posted 12/7/2025 7:00:00 AM- GlobeNewsWire

New Crypto Mutuum Finance Completes Phase 1 Roadmap Milestones, Builds Momentum Into Phase 2

Posted 12/7/2025 6:00:00 AM- GlobeNewsWire

Funding Reaches $19.2M as Mutuum Finance (MUTM) Presale Moves Toward Full Allocation

Posted 12/7/2025 4:00:00 AM- GlobeNewsWire

TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

Posted 12/6/2025 5:30:00 PM- GlobeNewsWire

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Posted 12/6/2025 5:30:00 PM- GlobeNewsWire

BioNTech and OncoC4 Announce Clinically Meaningful Overall Survival Benefit for Selective Treg Modulator Gotistobart in Patients with Previously Treated Squamous Non-Small Cell Lung Cancer

Posted 12/6/2025 3:30:00 PM- GlobeNewsWire

Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness

Posted 12/6/2025 2:01:02 PM- GlobeNewsWire

Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025

Posted 12/6/2025 2:00:00 PM- GlobeNewsWire

Evaxion presents new data for EVX-04, a cancer vaccine candidate for acute myeloid leukemia at ASH Annual Meeting

Posted 12/6/2025 2:00:00 PM- GlobeNewsWire

THE EFFICIENCY PARADOX: 5 Market Anomalies Trading Below Reality

Issued on behalf of Oncolytics Biotech Inc.

Posted 12/6/2025 1:51:21 PM- GlobeNewsWire

BexBack Launches $100 Welcome Bonus and 100% Deposit Match as It Expands 100x Crypto Futures Trading Program

Posted 12/6/2025 12:39:26 PM- GlobeNewsWire

Roofing Expert Keith Miller Clarifies Why Flashing Is the Source of Many Roof Leaks in HelloNation

Posted 12/6/2025 12:37:34 PM- GlobeNewsWire

RadiantVibe Capital Consortium Debuts Insight Access Dashboard as Part of Ambrose Wetherby’s Transparency Initiative

RadiantVibe Capital Consortium launches its Insight Access Dashboard to strengthen information clarity and support Ambrose Wetherby’s ongoing transparency initiative.

Posted 12/6/2025 12:00:00 PM- GlobeNewsWire

Mutuum Finance Completes Lending and Borrowing Smart Contracts Ahead of Security Review

Posted 12/6/2025 11:27:53 AM- GlobeNewsWire

Anthony Constantino’s ‘Thank You President Trump’ Album Release To Light Up Fontainebleau LIV Tonight; Hit song “Fight” has over 4 million views in 5 days

Posted 12/6/2025 11:24:14 AM- GlobeNewsWire

Prelude Therapeutics Presents Data at the 2025 ASH Annual Meeting from its Myeloproliferative Neoplasm (MPN) Programs

Posted 12/6/2025 11:00:00 AM- GlobeNewsWire

Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at 2025 American Society of Hematology (ASH) Annual Meeting

Posted 12/6/2025 10:15:00 AM- GlobeNewsWire

JCBC Publishing, LLC Announces Launch of 'That Kind of Girl,' Jacey Bici's Debut Novel, in 2025

Celebrated physician and author Jacey Bici unveils her first women's fiction novel, exploring transformative moments in women's lives.

Posted 12/6/2025 10:00:00 AM- GlobeNewsWire

Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)

Posted 12/6/2025 9:30:00 AM- GlobeNewsWire

Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition

Posted 12/6/2025 9:30:00 AM- GlobeNewsWire

Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting

Posted 12/6/2025 8:30:00 AM- GlobeNewsWire

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

Posted 12/6/2025 8:05:00 AM- GlobeNewsWire

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company's RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma

Posted 12/6/2025 8:05:00 AM- GlobeNewsWire

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

Posted 12/6/2025 8:00:00 AM- GlobeNewsWire

Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026

Posted 12/6/2025 8:00:00 AM- GlobeNewsWire

Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting

Posted 12/6/2025 8:00:00 AM- GlobeNewsWire

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

Posted 12/6/2025 8:00:00 AM- GlobeNewsWire

BI DeFi Launches New Daily Yield Plan as Demand for Accessible Crypto Income Solutions Grows

Posted 12/6/2025 7:15:00 AM- GlobeNewsWire

DeFi Crypto Mutuum Finance Prepares for 20% Price Increase as Phase 6 Nears Completion

Posted 12/6/2025 7:00:00 AM- GlobeNewsWire

New Crypto Coin Mutuum Finance Nears 100% of Phase 6 Allocation as Price Shift Approaches

Posted 12/6/2025 6:57:05 AM- GlobeNewsWire

Cardinal Point Wealth Management Releases New 2025 Cross-Border Retirement Guide for High-Net-Worth Families

Posted 12/6/2025 12:55:02 AM- GlobeNewsWire

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Posted 12/5/2025 10:11:15 PM- GlobeNewsWire

Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinson’s Disease

Posted 12/5/2025 9:00:00 PM- GlobeNewsWire

ORIC® Pharmaceuticals Presents Potential Best-in-Class Profile for Enozertinib with Robust Systemic and CNS Activity in 1L and 2L NSCLC Patients with EGFR Exon 20 Mutations at the ESMO Asia Congress 2025

Posted 12/5/2025 8:00:00 PM- GlobeNewsWire

HNI Corporation Announces Expiration and Final Results of Exchange Offer

Posted 12/5/2025 6:25:51 PM- GlobeNewsWire

Webus International Limited Issues Clarification on Previous Announcement Related to Expedia Group

Posted 12/5/2025 6:00:00 PM- GlobeNewsWire

LocationSync Releases New Consumer Insights Highlighting Nationwide Shift Toward Comfort-Driven Home Upgrades

Americans are accelerating home-focused improvements as lifestyle and technology trends reshape how they enhance daily living.

Posted 12/5/2025 5:17:13 PM- GlobeNewsWire

Rocket Doctor Announces Granting of RSUs and Options and a Change of CFO

Posted 12/5/2025 5:00:00 PM- GlobeNewsWire

Fly-E Group, Inc. Announces Receipt of Delinquency Notice from Nasdaq Regarding Delayed Form 10-Q

Posted 12/5/2025 5:00:00 PM- GlobeNewsWire

Connell Consulting Business Agency, LLC makes lobbying debut addressing Personal Injury Protection (PIP) loophole

Posted 12/5/2025 5:00:00 PM- GlobeNewsWire

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

Posted 12/5/2025 5:00:00 PM- GlobeNewsWire

CyberloQ Technologies, Inc to Present at the Small Cap Growth Virtual Investor Conference December 9th

Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com

Posted 12/5/2025 4:55:27 PM- GlobeNewsWire

Children’s National Hospital welcomes First Lady Melania Trump for holiday visit

Continuing a beloved tradition dating back to 1945, the First Lady visited Children’s National to read to patients, meet families and bring holiday warmth to those spending the season in the hospital.

Posted 12/5/2025 4:47:29 PM- GlobeNewsWire

USCB Financial Holdings, Inc. Portfolio Loss Restructuring

Posted 12/5/2025 4:30:00 PM- GlobeNewsWire

Parsons Selected As Lead Designer For $441 Million I-70 Rocheport To Columbia Design-Build Project

Posted 12/5/2025 4:30:00 PM- GlobeNewsWire

Global Mofy AI Limited Announces US$4.8 Million Private Placement Financing

Posted 12/5/2025 4:30:00 PM- GlobeNewsWire

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Posted 12/5/2025 4:30:00 PM- GlobeNewsWire

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Posted 12/5/2025 4:30:00 PM- GlobeNewsWire

Bimergen Energy Announces Uplist to the NYSE American Stock Exchange with Concurrent Offering

Posted 12/5/2025 4:15:00 PM- GlobeNewsWire

Omega Flex, Inc. Announces Regular Quarterly Dividend for the Fourth Quarter 2025

Posted 12/5/2025 4:15:00 PM- GlobeNewsWire

Quanex Building Products Declares Quarterly Dividend

Posted 12/5/2025 4:15:00 PM- GlobeNewsWire

ProCap BTC and Columbus Circle Capital Corp I Complete Business Combination

Posted 12/5/2025 4:14:51 PM- GlobeNewsWire

Performance Shipping Inc. Provides Update on Potential Forward Sale Agreement for M/T P. Sophia

Posted 12/5/2025 4:10:00 PM- GlobeNewsWire

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

Posted 12/5/2025 4:10:00 PM- GlobeNewsWire

Sunrise Signs 5,000-Ton Anode Material Supply Contract With Pylontech, Expanding Into the European Residential Energy Storage Market

Posted 12/5/2025 4:10:00 PM- GlobeNewsWire

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Posted 12/5/2025 4:05:00 PM- GlobeNewsWire

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Posted 12/5/2025 4:05:00 PM- GlobeNewsWire

Meihua International Medical Technologies Co., Ltd. Received Nasdaq Delisting Notice

Posted 12/5/2025 4:05:00 PM- GlobeNewsWire

Pheton Holdings Ltd Announces Closing of Share Acquisition with iTonic Corporation

Posted 12/5/2025 4:05:00 PM- GlobeNewsWire

Spyre Therapeutics Announces Grants of Inducement Awards

Posted 12/5/2025 4:05:00 PM- GlobeNewsWire

Bahamasair and Emirates Partnership Activated, Offering Direct Connections to Nassau and Freeport

Posted 12/5/2025 4:04:21 PM- GlobeNewsWire

Announcement relating to despatch of Rule 15 proposal

Posted 12/5/2025 4:01:00 PM- GlobeNewsWire

Parsons Selected for $1B Sound Transit MATOC to Support Regional Transit Expansion

Posted 12/5/2025 4:01:00 PM- GlobeNewsWire

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Posted 12/5/2025 4:01:00 PM- GlobeNewsWire

Hingham Savings Authorizes Stock Repurchase Program

Posted 12/5/2025 4:01:00 PM- GlobeNewsWire